vs
Assertio Holdings, Inc.(ASRT)与Pioneer Bancorp, Inc.(PBFS)财务数据对比。点击上方公司名可切换其他公司
Pioneer Bancorp, Inc.的季度营收约是Assertio Holdings, Inc.的1.8倍($25.0M vs $13.5M),过去两年Pioneer Bancorp, Inc.的营收复合增速更高(144.9% vs -35.4%)
Assertio Therapeutics是一家美国专业制药企业,主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年,总部位于加利福尼亚州纽瓦克,拥有多款获美国FDA批准的产品,目前在纳斯达克上市。
先锋银行控股公司(马里兰州)是一家美国银行控股企业,为先锋银行的母公司,主要面向马里兰州本地社区用户提供零售及商业银行服务,涵盖存款账户、住房与商业抵押贷款、消费贷款及小微企业融资等产品。
ASRT vs PBFS — 直观对比
营收规模更大
PBFS
是对方的1.8倍
$13.5M
两年增速更快
PBFS
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.5M | $25.0M |
| 净利润 | — | $3.7M |
| 毛利率 | — | — |
| 营业利润率 | -86.7% | 21.3% |
| 净利率 | — | 82.1% |
| 营收同比 | -57.9% | — |
| 净利润同比 | — | — |
| 每股收益(稀释后) | $-4.54 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASRT
PBFS
| Q4 25 | $13.5M | $25.0M | ||
| Q3 25 | $49.5M | $24.0M | ||
| Q2 25 | $29.2M | $24.4M | ||
| Q1 25 | $26.5M | $22.8M | ||
| Q4 24 | $32.2M | — | ||
| Q3 24 | $29.2M | $22.0M | ||
| Q2 24 | $31.1M | $20.9M | ||
| Q1 24 | $32.4M | $21.6M |
净利润
ASRT
PBFS
| Q4 25 | — | $3.7M | ||
| Q3 25 | $11.4M | $4.3M | ||
| Q2 25 | $-16.4M | $6.5M | ||
| Q1 25 | $-13.5M | $5.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.9M | $6.3M | ||
| Q2 24 | $-3.7M | $3.9M | ||
| Q1 24 | $-4.5M | $4.7M |
营业利润率
ASRT
PBFS
| Q4 25 | -86.7% | 21.3% | ||
| Q3 25 | 23.2% | 23.4% | ||
| Q2 25 | -27.5% | 33.3% | ||
| Q1 25 | -50.0% | 32.5% | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | -10.4% | 37.2% | ||
| Q2 24 | -11.6% | 24.1% | ||
| Q1 24 | -13.4% | 28.1% |
净利率
ASRT
PBFS
| Q4 25 | — | 82.1% | ||
| Q3 25 | 23.1% | 18.0% | ||
| Q2 25 | -56.0% | 26.4% | ||
| Q1 25 | -51.1% | 25.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.0% | 28.7% | ||
| Q2 24 | -11.8% | 107.4% | ||
| Q1 24 | -13.9% | 21.9% |
每股收益(稀释后)
ASRT
PBFS
| Q4 25 | $-4.54 | $0.16 | ||
| Q3 25 | $0.11 | $0.18 | ||
| Q2 25 | $-0.17 | $0.26 | ||
| Q1 25 | $-0.14 | $0.23 | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | $0.25 | ||
| Q2 24 | $-0.04 | $0.15 | ||
| Q1 24 | $-0.05 | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $323.9M |
| 总资产 | $267.0M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASRT
PBFS
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务
ASRT
PBFS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益
ASRT
PBFS
| Q4 25 | $94.0M | $323.9M | ||
| Q3 25 | $105.8M | $314.2M | ||
| Q2 25 | $93.3M | $314.2M | ||
| Q1 25 | $108.5M | $310.7M | ||
| Q4 24 | $121.1M | — | ||
| Q3 24 | $130.5M | $303.8M | ||
| Q2 24 | $132.2M | $296.5M | ||
| Q1 24 | $134.5M | $289.0M |
总资产
ASRT
PBFS
| Q4 25 | $267.0M | $2.2B | ||
| Q3 25 | $319.8M | $2.2B | ||
| Q2 25 | $273.8M | $2.1B | ||
| Q1 25 | $286.4M | $2.1B | ||
| Q4 24 | $284.7M | — | ||
| Q3 24 | $276.0M | $2.0B | ||
| Q2 24 | $279.4M | — | ||
| Q1 24 | $282.0M | $2.0B |
负债/权益比
ASRT
PBFS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $11.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 2.97× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ASRT
PBFS
| Q4 25 | $-30.0M | $11.1M | ||
| Q3 25 | $-4.8M | $3.9M | ||
| Q2 25 | $19.1M | $5.1M | ||
| Q1 25 | $-12.5M | $-3.5M | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $-35.0K | $1.9M | ||
| Q2 24 | $7.4M | $9.0M | ||
| Q1 24 | $7.5M | $3.3M |
资本支出强度
ASRT
PBFS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率
ASRT
PBFS
| Q4 25 | — | 2.97× | ||
| Q3 25 | -0.42× | 0.90× | ||
| Q2 25 | — | 0.78× | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
PBFS
暂无分部数据